Developmental Research Program

$680,492U54FY2009AINIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications & trials

Paper 37787543 Paper 33636719 Paper 33328346 Paper 33140052 Paper 30982830 Paper 30463877 Paper 29950379 Paper 28329306 Paper 28230053 Paper 28183184 Paper 27899441 Paper 27715466 Paper 27600507 Paper 27585799 Paper 27337282 Paper 27336950 Paper 27276177 Paper 27185081 Paper 26958720 Paper 26939124 Paper 26919416 Paper 26868915 Paper 26718339 Paper 26711522 Paper 26631631 Paper 26507236 Paper 26497246 Paper 26483409 Paper 26468544 Paper 26283727 Paper 26256460 Paper 26184960 Paper 26079000 Paper 25968648 Paper 25951191 Paper 25934793 Paper 25870274 Paper 25830414 Paper 25829141 Paper 25748385 Paper 25689254 Paper 25679759 Paper 25595799 Paper 25589639 Paper 25587492 Paper 25572397 Paper 25514971 Paper 25389186 Paper 25348152 Paper 25215485 Paper 25211074 Paper 25165815 Paper 25150294 Paper 25080348 Paper 25063986 Paper 25002546 Paper 24987096 Paper 24917594 Paper 24854422 Paper 24846574 Paper 24815087 Paper 24808237 Paper 24803533 Paper 24799630 Paper 24795478 Paper 24781747 Paper 24699424 Paper 24634498 Paper 24618252 Paper 24599533 Paper 24574415 Paper 24570370 Paper 24564980 Paper 24558222 Paper 24517260 Paper 24478317 Paper 24412922 Paper 24412542 Paper 24401277 Paper 24389148 Paper 24388756 Paper 24379209 Paper 24333484 Paper 24284630 Paper 24244168 Paper 24184127 Paper 24121441 Paper 24109225 Paper 24067973 Paper 24067954 Paper 24034612 Paper 24024573 Paper 24011402 Paper 24003229 Paper 24003179 Paper 23965845 Paper 23925275 Paper 23922375 Paper 23903846 Paper 23880062

Abstract

The Developmental Projects Program funds early-stage research projects with the potential to develop into more substantial research programs. Its objective is to promote innovative research in areas that can translate into the development of new vaccines, therapeutics and/or diagnostics to combat Category A-C select agents or other emerging infectious pathogens. The Developmental Projects Program invests in initiatives having the greatest potential to compete for traditional National Institutes of Health (NIH) funding Project support will be provided for up to 24 months, with an annual budget between $100,000 and $125,000 in direct costs. The intent is to fund "higher-risk" research, requiring less preliminary data than a conventional R01 grant. The Program also seeks to attract Region II investigators with novel approaches, who may not presently be working in the area of biodefense. The Developmental Projects Program encourages collaborations among investigators involved in basic and clinical microbiology research and others in immunology, cell biology, chemical biology, and bioinformatics. To create the most fertile environment for discovery, strategic investments will be directed to novel projects with the potential for high return and a good probability of qualifying for future NIH funding.

View original record on NIH RePORTER →